 |
|
|
| |
Real-World Experience with Higher-Than-Recommended
Doses of Lamivudine in Patients with Varying Degrees of Renal Impairment
|
| |
| |
Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego
Briann Luteran, PharmD, BCACP, Leonard Berkowitz, MD , Anjali Bakshi, MD , Kushal Shah,PhD Candidate, David Taft, PhD , Agnes Cha, PharmD, AAHIVP, BCACP
The Brooklyn Hospital Center, Brooklyn, NY , Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York
|
| |
|
|
|
|
|
